GlassScriptPhysician profile
Mohammad A Abdul Waheed
NPI 1790996080
$9,503.62
in general payments reported to CMS, 2019-2025
45 companies · $1,161 in 2025
The $1,161 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,102 · 2020: $449 · 2021: $721 · 2022: $1,358 · 2023: $1,844 · 2024: $868 · 2025: $1,161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,622 · Travel and Lodging: $1,251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,622.37 |
| Travel and Lodging | $1,251.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,681.85 | 2019-2025 | Mitraclip, Amplatzer Amulet |
| Medtronic, INC. | $1,296.29 | 2021-2025 | Corevalve Evolut R |
| Novartis Pharmaceuticals Corporation | $720.16 | 2019-2024 | |
| Abiomed | $606.31 | 2019-2025 | Impella |
| Ge Healthcare | $434.90 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $382.70 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $333.65 | 2019-2024 | Brilinta |
| Pfizer INC. | $309.36 | 2022-2025 | |
| Medtronic Vascular, INC. | $241.48 | 2019-2020 | |
| Medical Device Business Services, INC. | $230.83 | 2024 | Carto 3 |
| Chiesi USA, INC. | $228.92 | 2019-2023 | Kengreal |
| E.R. Squibb & Sons, L.L.C. | $223.50 | 2019-2025 | Eliquis, Camzyos |
| Amgen INC. | $141.78 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $136.90 | 2019-2022 | |
| Shockwave Medical, INC | $136.73 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $113.25 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $97.28 | 2019-2024 | Opsumit, Uptravi |
| Inari Medical, INC. | $92.82 | 2019-2022 | |
| Stryker Corporation | $87.92 | 2025 | Flowtriever |
| Philips North America LLC | $83.82 | 2020-2023 | |
| Baxter Healthcare | $77.51 | 2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Metaneb System, Hillrom - Vest System Model 105 Home Care |
| Sanofi-Aventis U.S. LLC | $76.62 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $75.20 | 2021-2023 | Verquvo |
| Terumo Medical Corporation | $68.93 | 2020-2023 | Glidewire |
| Alnylam Pharmaceuticals INC. | $65.53 | 2021-2024 | Onpattro |
| Heartflow, INC. | $50.07 | 2025 | |
| Edwards Lifesciences Corporation | $47.12 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Novo Nordisk INC | $46.12 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Vifor Pharma, INC. | $43.59 | 2025 | Zemaira |
| Osprey Medical INC | $40.00 | 2019 | |
| Thrombolex, INC. | $39.85 | 2024-2025 | Bashir Endovascular Catheter |
| Esperion Therapeutics, INC. | $35.80 | 2021 | |
| La Jolla Pharmaceutical Company | $34.64 | 2021-2024 | Giapreza |
| Kiniksa Pharmaceuticals, LTD. | $33.36 | 2023 | Arcalyst |
| Mayne Pharma Commercial LLC | $29.06 | 2020 | |
| Amarin Pharma, INC. | $25.46 | 2019 | |
| Portola Pharmaceuticals, LLC | $18.76 | 2019 | |
| Cardiva Medical, INC. | $18.56 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Corindus INC. | $18.19 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.09 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.80 | 2022 | |
| Ekos Corporation | $13.64 | 2019 | |
| Cvrx, INC. | $13.07 | 2023 | Barostim Neo System |
| Siemens Medical Solutions USA, INC. | $12.82 | 2020 | |
| Insmed, INC. | $11.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Abdul Waheed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.